Amanda Massmann

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Antiplatelet Therapy

St Segment Elevation Myocardial Infarction

Patient Satisfaction

Clinical Decision Support

Top Venues

Pharmacogenomics

European journal of human genetics : EJHG

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Joel Van Heukelom, Max Weaver, April Schultz, Debbie M Figueroa, Adam Stys, Tomasz P Stys, Kurt D Christensen
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel. Pharmacogenomics (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG (2024)
Amanda Massmann, Joel Van Heukelom, Robert C Green, Catherine Hajek, Madison R Hickingbotham, Eric A Larson, Christine Y Lu, Ann Chen Wu, Emilie S Zoltick, Kurt D Christensen, April Schultz
SLCO1B1 gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatin. Pharmacogenomics (2023)
Joel Van Heukelom, Kristen Jacobsen, Natasha J Petry, April Schultz, Jordan F Baye, David Sturdevant, Amanda Massmann
Patient satisfaction with return of pharmacogenomic results utilizing a patient portal message. Pharmacogenomics (2023)
Savannah Collett, Amanda Massmann, Natasha J Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F Baye
Metoprolol and CYP2D6 : A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of personalized medicine 13 (3) (2023)
Charlene L Preys, Carrie L Blout Zawatsky, Amanda Massmann, Joel Van Heukelom, Robert C Green, Catherine A Hajek, Madison R Hickingbotham, Emilie S Zoltick, April Schultz, Kurt D Christensen
Attitudes about pharmacogenomic testing vary by healthcare specialty. Pharmacogenomics (2023)
Savannah Collett, Amanda Massmann, Natasha J Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F Baye
Metoprolol and CYP2D6 : A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of personalized medicine 13 (3) (2023)
Savannah Collett, Amanda Massmann, Natasha J Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F Baye
Metoprolol and CYP2D6 : A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of personalized medicine 13 (3) (2023)
Sarah C Mills, Amanda Massmann
Congruence rates for pharmacogenomic noninterruptive alerts. Pharmacogenomics (2023)
Amanda Massmann, Joel Van Heukelom, Chad Larson, Rachel D Starks
Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics results. Pharmacogenomics 23 (18) (2022)
Natasha J Petry, Jordan F Baye, Samantha Frear, Kristen Jacobsen, Amanda Massmann, April Schultz, Joel Van Heukelom, Kurt Christensen
Progression of precision statin prescribing for reduction of statin-associated muscle symptoms. Pharmacogenomics 23 (10) (2022)